SYDNEY,
OCTOBER 19
INDIAN ABROAD NEWSDESK
Health authorities in New South Wales have warned consumers about the risks of unapproved peptide products after a sharp rise in emergency department presentations associated with their use.
In a statement released on October 19, NSW Health said surveillance data recorded 1,180 emergency department presentations associated with peptide use between July 1, 2025, and September 30, 2026. Monthly presentations rose from five in July 2025 to more than 217 in September 2026.
Some peptide products are promoted through social media and online fitness communities for weight loss, injury recovery, muscle development or anti-ageing. However, NSW Health warned that a number of products marketed for these purposes are not approved for use in Australia.
Peptides are short chains of amino acids, and some have legitimate medical applications. The concern is with unapproved products whose ingredients, quality, safety and effects may not be adequately established.
For people pursuing fitness and wellness goals, the warning is a reminder that products advertised online are not necessarily safe simply because they are described as scientific or medically inspired.
The NSW figures relate to emergency department presentations associated with peptide use; they should not be interpreted as proof that every presentation resulted from a confirmed adverse reaction.
The health department’s warning highlights the need for better consumer awareness and responsible marketing of products sold for performance and wellness purposes.
